Vidavo (ATH:VIDAVO) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATH:VIDAVO Vidavo SA ATH:VIDAVO
84 GF Score
Price €9.50
GF Value €8.57
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vidavo Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

ATH:VIDAVO
84GF Score
Vidavo SA ATH:VIDAVO
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vidavo (ATH:VIDAVO) Overvalued in 2026?

Based on GuruFocus' analysis, Vidavo stock appears to be overvalued. The current stock price of €9.50 is trading 10.9% above its estimated GF Value™ of €8.57. GuruFocus considers Vidavo to be Modestly Overvalued.

Key valuation signals for ATH:VIDAVO:

  • Dividends Received:
  • GF Value™: €8.57 vs. price of €9.50 (10.9% above fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the ATH:VIDAVO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vidavo Business Description

Address 10th km Thessalonikis - N. Moudanion, Balkan Center, Building D, Thessaloniki, GRC, 57001
Vidavo SA develops mobile applications that help citizens on-the-move and medical professionals manage health and wellness. The company serves health and social care providers, policymakers, insurance companies, ICT firms seeking differentiation, patients, telecom operators, and other health-related stakeholders. Its solutions include vida24, vidatrack, and vidahome.
84GF Score

Get the complete analysis for ATH:VIDAVO

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.50
Price
€8.57
GF Value